加载页面时好像出了点问题.
我们的团队已经注意到了，但如果问题仍然存在，请使用电子邮件支持小工具联系我们。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 139.7x - 154.4x | 147.1x |
| Selected Fwd Ps Multiple | 29.6x - 32.7x | 31.1x |
| Fair Value | 0.42$ - 0.46$ | 0.44$ |
| Upside | -15.9% - -7.0% | -11.4% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Daxor Corporation | - | NasdaqCM:DXR |
| Glaukos Corporation | - | NYSE:GKOS |
| Penumbra, Inc. | - | NYSE:PEN |
| ICU Medical, Inc. | - | NasdaqGS:ICUI |
| Escalon Medical Corp. | - | OTCPK:ESMC |
| BioSig Technologies, Inc. | - | NasdaqCM:BSGM |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| DXR | GKOS | PEN | ICUI | ESMC | BSGM | |||
| NasdaqCM:DXR | NYSE:GKOS | NYSE:PEN | NasdaqGS:ICUI | OTCPK:ESMC | NasdaqCM:BSGM | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | -20.6% | 10.1% | 16.9% | 13.5% | 4.5% | NM- | ||
| 3Y CAGR | -24.5% | 9.3% | 16.9% | 21.9% | 4.6% | NM- | ||
| Latest Twelve Months | -26.7% | 21.9% | 12.9% | 5.4% | -1.7% | -72.3% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 734.4% | -33.2% | 1.5% | 1.7% | -1.2% | NA | ||
| Prior Fiscal Year | 171.7% | -42.8% | 8.6% | -1.3% | 1.8% | -9535.3% | ||
| Latest Fiscal Year | 448.0% | -38.2% | 1.2% | -4.9% | -1.5% | -161388.9% | ||
| Latest Twelve Months | 448.0% | -38.2% | 1.2% | -4.9% | 0.4% | -39605.1% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | NA | -81.0x | 76.9x | 15.8x | 7.0x | NA | ||
| Price / LTM Sales | 335.9x | 15.9x | 9.2x | 1.5x | 0.1x | NA | ||
| LTM P/E Ratio | 75.0x | -41.6x | 786.8x | -31.2x | 29.3x | NA | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 0.1x | 9.2x | 335.9x | |||||
| Historical LTM P/S Ratio | 0.0x | NM | 0.0x | |||||
| Selected Price / Sales Multiple | 139.7x | 147.1x | 154.4x | |||||
| (x) LTM Sales | 0 | 0 | 0 | |||||
| (=) Equity Value | 5 | 6 | 6 | |||||
| (/) Shares Outstanding | 17.2 | 17.2 | 17.2 | |||||
| Implied Value Range | 0.32 | 0.33 | 0.35 | |||||
| FX Rate: USD/USD | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 0.32 | 0.33 | 0.35 | 0.49 | ||||
| Upside / (Downside) | -36.0% | -32.6% | -29.2% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | DXR | GKOS | PEN | ICUI | ESMC | BSGM | |
| Value of Common Equity | 40 | 6,084 | 11,024 | 3,673 | 1 | 9 | |
| (/) Shares Outstanding | 4.9 | 56.5 | 38.5 | 24.5 | 7.4 | 17.2 | |
| Implied Stock Price | 8.15 | 107.61 | 286.23 | 149.82 | 0.18 | 0.49 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 8.15 | 107.61 | 286.23 | 149.82 | 0.18 | 0.49 | |
| Trading Currency | USD | USD | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |